Aloe Blacc’s fame means nothing in biotech (and that’s the point)

Aloe Blacc’s fame means nothing in biotech (and that’s the point)

When Grammy-nominated singer-songwriter Aloe Blacc got COVID despite being vaccinated and boosted, he tried to fund research for a better solution. What he quickly found out? You can’t just write a check in biotech. Regulators require a commercialization plan, and philanthropy doesn’t move science through clinical trials or get you a license on university IP. Now, he’s bootstrapping a cancer drug platform targeting pancreatic cancer, a disease that kills 90% of its patients, and intentionally waiting to raise from his network until peer-reviewed papers can make his case. 

Watch as Aloe Blacc joins Rebecca Bellan on TechCrunch’s Equity podcast to talk about what happens when a creator decides to build instead of just invest, how Aloe is watching AI reshape both the biotech and music industries in real time, and his thoughts on who actually wins. 

Subscribe to Equity on YouTube, Apple Podcasts, Overcast, Spotify and all the casts. You also can follow Equity on X and Threads, at @EquityPod. 

Theresa Loconsolo is an audio producer at TechCrunch focusing on Equity, the network’s flagship podcast. Before joining TechCrunch in 2022, she was one of 2 producers at a four-station conglomerate where she wrote, recorded, voiced and edited content, and engineered live performances and interviews from guests like lovelytheband. Theresa is based in New Jersey and holds a bachelors degree in Communication from Monmouth University.

You can contact or verify outreach from Theresa by emailing theresa.loconsolo@techcrunch.com.

View Bio

Newsletters

Subscribe for the industry’s biggest tech news

Related

Προωθημένο
Προωθημένο
Upgrade to Pro
διάλεξε το πλάνο που σου ταιριάζει
Προωθημένο
Προωθημένο
Διαφημίσεις
Διαβάζω περισσότερα
Download the Telestraw App!
Download on the App Store Get it on Google Play
×